clinical trial development

Australis is a global biopharmaceutical company developing cancer therapies, centered on its lead compound AUS_001, a naturally derived compound discovered in honeybee propolis from Kangaroo Island. Its in-house research is based at a laboratory in Simi Valley, California, staffed by PhD scientists, with third-party research performed worldwide. AUS_001 has shown pre-clinical efficacy against 24 types of cancer and has received FDA Orphan Drug Designation for malignant gliomas and Rare Pediatric Disease Designation for pediatric-type diffuse high-grade g

Read more

drug formulationGLP toxicology studiesin vitro and in vivo studiespre-clinical research

Cognosci Inc. was founded in May 2000 to develop anti-inflammatory compounds for the treatment of neuroinflammatory diseases including Multiple Sclerosis, Alzheimer's Disease, and brain bleeding events. The company is discovering and developing therapeutic compounds based on the apoE protein, small patented synthetic peptides of ten to seventeen amino acids with anti-inflammatory and neuroprotective activity. Cognosci purchased rights to an APOE-based compound from Duke University and has engineered over 500 new compounds.

Read more

compound engineeringdrug discoverylead optimizationpreclinical development